International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Enhancing biopharmaceutical supply chains: Strategies for efficient drug formulary development in emerging markets

Oluchukwu Obinna Ogbuagu, Akachukwu Obianuju Mbata, Obe Destiny Balogun, Olajumoke Oladapo, Opeyemi Olaoluawa Ojo, Muridzo Muonde

Sanofil, Nigeria; Kaybat Pharmacy and Stores, Benin, Nigeria; Independent Researcher, Lima Ohio, USA; Health Mark Regional Medical Center Florida, USA; Medical Statistician, University of Medical Science Teaching Hospital Ondo, Nigeria; Africure Pharmaceuticals Namibia

Article Information

Volume / Issue3 / 1 (January-March 2022)
Pages73-82
AccessOpen Access

Publication Timeline

  • Received12 January 2022
  • Accepted13 February 2022

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Biopharmaceutical supply chains in emerging markets face numerous challenges that hinder the efficient development and distribution of essential medicines. These challenges include regulatory barriers, infrastructure deficiencies, logistical inefficiencies, and market volatility. This paper explores strategic approaches to optimizing drug formulary development within these contexts, highlighting the importance of data-driven decision-making, regulatory harmonization, and public-private partnerships. The research also discusses technological innovations, such as blockchain, IoT, and automation, which can enhance supply chain operations' transparency, traceability, and efficiency. By identifying these challenges and proposing actionable solutions, this paper offers recommendations for policymakers, industry leaders, and healthcare providers to strengthen supply chains and improve access to life-saving drugs. Future research directions are also outlined, focusing on the role of digital transformation, sustainable supply chain models, and regulatory advancements. Ultimately, this paper aims to contribute to the ongoing efforts to enhance drug formulary development and supply chain efficiency, ensuring equitable access to affordable medicines in emerging markets.

Keywords

Biopharmaceutical supply chainsdrug formulary developmentregulatory harmonizationpublic-private partnershipstechnological innovationssustainable procurement

References

  1. Abbott KW, Snidal D. The governance triangle: Regulatory standards institutions and the shadow of the state. In: The spectrum of international institutions. Routledge; c2021. p. 52-91. [Google Scholar][Crossref]
  2. Abdulmalek S, Nasir A, Jabbar WA, Almuhaya MA, Bairagi AK, Khan MA-M, et al. IoT-based healthcare-monitoring system towards improving quality of life: A review. Paper presented at: Healthcare; c2022. [Google Scholar][Crossref]
  3. Algorri M, Abernathy MJ, Cauchon NS, Christian TR, Lamm CF, Moore CM. Re-envisioning pharmaceutical manufacturing: increasing agility for global patient access. J Pharm Sci. 2022;111(3):593-607. [Google Scholar][Crossref]
  4. Bamakan SMH, Moghaddam SG, Manshadi SD. Blockchain-enabled pharmaceutical cold chain: Applications, key challenges, and future trends. J Clean Prod. 2021;302:127021. [Google Scholar][Crossref]
  5. Berdud M, Chalkidou K, Dean EB, Ferraro J, Garrison L, Nemzoff C, et al. The future of global health procurement: issues around pricing transparency. [Google Scholar][Crossref]
  6. Burns L, Le Roux N, Kalesnik-Orszulak R, Christian J, Hukkelhoven M, Rockhold F, et al. Real-world evidence for regulatory decision-making: guidance from around the world. Clin Ther. 2022;44(3):420-437. [Google Scholar][Crossref]
  7. Buxton J, Bingham T. The rise and challenge of dark net drug markets. Policy brief. 2015;7(2):1-24. [Google Scholar][Crossref]
  8. Calder A. Assessment of potential barriers to medicines regulatory harmonization in the Southern African Development Community (SADC) region. 2016. [Google Scholar][Crossref]
  9. Chung YH, Church D, Koellhoffer EC, Osota E, Shukla S, Rybicki EP, et al. Integrating plant molecular farming and materials research for next-generation vaccines. Nat Rev Mater. 2022;7(5):372-388. [Google Scholar][Crossref]
  10. Dhaliwal A. The rise of automation and robotics in warehouse management. In: Transforming Management Using Artificial Intelligence Techniques. CRC Press; c2020. p. 63-72. [Google Scholar][Crossref]
  11. Dhiman SK, Gummadi V, Dureja H. Partnership efforts– Their potential to reduce the challenges that confront regulators and pharmaceutical industry. Appl Clin Res Clin Trials Regul Aff. 2019;6(1):7-17. [Google Scholar][Crossref]
  12. Ding B. Pharma Industry 4.0: Literature review and research opportunities in sustainable pharmaceutical supply chains. Process Saf Environ Prot. 2018;119:115-130. [Google Scholar][Crossref]
  13. Dinh H. The Revolution of Warehouse Inventory Management by Using Artificial Intelligence: Case Warehouse of Company X. 2020. International Journal of Medical and All Body Health Research www.allmedicaljournal.com [Google Scholar][Crossref]
  14. Edoh NL, Ukpabi UJ, Igol JO. Untargeted metabolomics profiling of high beta carotene cassava with respect to postharvest physiological deterioration. 2021. [Google Scholar][Crossref]
  15. Edoh NL, Ukpabi UJ, Igoli JO. Effect of scopoletin and carotenoids on postharvest physiological deterioration (PPD) of transgenic high beta carotene cassava. J Food Res. 2021;10(4):1-9. [Google Scholar][Crossref]
  16. Gillespie JJ, Privitera GJ, Gaspero J. Biopharmaceutical entrepreneurship, open innovation, and the knowledge economy. J Innov Manag. 2019;7(2):59-77. [Google Scholar][Crossref]
  17. Harrison RP, Ruck S, Medcalf N, Rafiq Q A. Decentralized manufacturing of cell and gene therapies: Overcoming challenges and identifying opportunities. Cytotherapy. 2017;19(10):1140-1151. [Google Scholar][Crossref]
  18. Hirsch G, Trusheim M, Cobbs E, Bala M, Garner S, Hartman D, et al. Adaptive biomedical innovation: evolving our global system to sustainably and safely bring new medicines to patients in need. Clin Pharmacol Ther. 2016;100(6):685-698. [Google Scholar][Crossref]
  19. Ibrahim T, Araujo CA. Biopharmaceutical supply chain challenges in developing countries: an exploratory analysis. Paper presented at: Supply Chain Forum: An Int J; c2021. [Google Scholar][Crossref]
  20. Koçkaya G, Wertheimer A. Pharmaceutical market access in emerging markets: SEEd. 2016. [Google Scholar][Crossref]
  21. Kohler JC, Martinez MG, Petkov M, Sale J. Corruption in the pharmaceutical sector: diagnosing the challenges. 2016. [Google Scholar][Crossref]
  22. Ma J-Y, Shi L, Kang T-W. The effect of digital transformation on the pharmaceutical sustainable supply chain performance: The mediating role of information sharing and traceability using structural equation modeling. Sustainability. 2022;15(1):649. [Google Scholar][Crossref]
  23. Mackey TK, Nayyar G. A review of existing and emerging digital technologies to combat the global trade in fake medicines. Expert Opin Drug Saf. 2017;16(5):587-602. [Google Scholar][Crossref]
  24. Masheti C. E-procurement practices and operational performance of pharmaceutical manufacturing firms in Nairobi. University of Nairobi; c2016. [Google Scholar][Crossref]
  25. Mello MM. What makes ensuring access to affordable prescription drugs the hardest problem in health policy. Minn L Rev. 2017;102:2273. [Google Scholar][Crossref]
  26. Myles L, Church TD. An industry survey of implementation strategies for clinical supply chain management of cell and gene therapies. Cytotherapy. 2022;24(3):344-355. [Google Scholar][Crossref]
  27. Neumann PJ, Cohen JT, Ollendorf DA. The right price: a value-based prescription for drug costs. Oxford University Press; c2021. [Google Scholar][Crossref]
  28. Nguyen A, Lamouri S, Pellerin R, Tamayo S, Lekens B. Data analytics in pharmaceutical supply chains: state of the art, opportunities, and challenges. Int J Prod Res. 2022;60(22):6888-6907. [Google Scholar][Crossref]
  29. Organization WH. China policies to promote local production of pharmaceutical products and protect public health. World Health Organization; c2017. [Google Scholar][Crossref]
  30. Organization WH. Technical report: pricing of cancer medicines and its impacts: a comprehensive technical report for the World Health Assembly Resolution 70.12: operative paragraph 2.9 on pricing approaches and their impacts on availability and affordability of medicines for the prevention and treatment of cancer. 2018. [Google Scholar][Crossref]
  31. Ozkan N. Fostering Digital Marketplaces in Logistics and Supply Chain: Trends and Opportunities. Politecnico di Torino; c2020. [Google Scholar][Crossref]
  32. Panda SK, Satapathy SC. Drug traceability and transparency in medical supply chain using blockchain for easing the process and creating trust between stakeholders and consumers. Pers Ubiquitous Comput. 2021;1-17. [Google Scholar][Crossref]
  33. Pojani D, Stead D. Sustainable urban transport in the developing world: beyond megacities. Sustainability. 2015;7(6):7784-7805. [Google Scholar][Crossref]
  34. Pojani D, Stead D. The urban transport crisis in emerging economies: An introduction. Springer; c2017. [Google Scholar][Crossref]
  35. Ragavan S, Vanni A. Intellectual property law and access to medicines: TRIPS agreement, health, and pharmaceuticals. Taylor & Francis; c2021. [Google Scholar][Crossref]
  36. Sarkis M, Bernardi A, Shah N, Papathanasiou MM. Emerging challenges and opportunities in pharmaceutical manufacturing and distribution. Processes. 2021;9(3):457. [Google Scholar][Crossref]
  37. Seyedan M, Mafakheri F. Predictive big data analytics for supply chain demand forecasting: methods, applications, and research opportunities. J Big Data. 2020;7(1):53. [Google Scholar][Crossref]
  38. Shankar V, Grewal D, Sunder S, Fossen B, Peters K, Agarwal A. Digital marketing communication in global marketplaces: A review of extant research, future directions, and potential approaches. Int J Res Mark. 2022;39(2):541-565. [Google Scholar][Crossref]
  39. Sharma DK, Gupta P. Internet of Things: The new Rx for pharmaceutical manufacturing and supply chains. In: An Industrial IoT Approach for Pharmaceutical Industry Growth. Elsevier; c2020. p. 257-288. [Google Scholar][Crossref]
  40. Shashi M. Digital Strategies to improve the performance of pharmaceutical supply chains. Walden University; c2022. [Google Scholar][Crossref]
  41. Singh RK, Kumar R, Kumar P. Strategic issues in pharmaceutical supply chains: a review. Int J Pharm Healthcare Mark. 2016;10(3):234-257. [Google Scholar][Crossref]
  42. Smyth SJ, Webb SR, Phillips PW. The role of public-private partnerships in improving global food security. Global Food Sec. 2021;31:100588. [Google Scholar][Crossref]
  43. Sople VV. Managing intellectual property: The strategic imperative. PHI Learning Pvt. Ltd.; c2016. [Google Scholar][Crossref]
  44. Sun Y, Ali SI. Internet of things (IoT) and blockchain applications in pharmaceutical supply chain provenance to achieve traceability, transparency, and authenticity. In: Advancing Smarter and More Secure Industrial Applications Using AI, IoT, and Blockchain Technology. IGI Global; c2022. p. 1-36. [Google Scholar][Crossref]
  45. Tusé D, Nandi S, McDonald KA, Buyel JF. The emergency response capacity of plant-based biopharmaceutical manufacturing-what it is and what it could be. Front Plant Sci. 2020;11:594019. [Google Scholar][Crossref]
  46. Vogler S, Zimmermann N, Haasis A, Babar-Ud-Din Z, Busse R, Espin Balbino J. Can pharmaceutical pricing and reimbursement policies make a difference in promoting equitable access to affordable medicines? From diagnosis to sustainable impact. Editorial. 2019. [Google Scholar][Crossref]
  47. Wang Y, Kung L, Wang WY-C, Cegielski CG. An integrated big data analytics-enabled transformation model: Application to health care. Inf Manag. 2018;55(1):64-79. [Google Scholar][Crossref]
  48. Winegarden W. Improving market efficiencies will promote greater drug affordability. Pacific Research International Journal of Medical and All Body Health Research www.allmedicaljournal.com Institute; c2 020. Available from: https://www.pacificresearch.org/wp. [Google Scholar][Crossref]
  49. Yoo S-L, Kim D-J, Lee S-M, Kang W-G, Kim S-Y, Lee JH, et al. Improving patient access to new drugs in South Korea: evaluation of the national drug formulary system. Int J Environ Res Public Health. 2019;16(2):288. [Google Scholar][Crossref]
  50. Zhu X, Ninh A, Zhao H, Liu Z. Demand forecasting with supply‐chain information and machine learning: Evidence in the pharmaceutical industry. Prod Oper Manag. 2021;30(9):3231-3252. [Google Scholar][Crossref]

How to Cite

Ogbuagu, O. O., Mbata, A. O., Balogun, O. D., Oladapo, O., Ojo, O. O., & Muonde, M. (2022). Enhancing biopharmaceutical supply chains: Strategies for efficient drug formulary development in emerging markets. International Journal of Medical and All Body Health Research, 3(1), 73-82. https://doi.org/10.54660/IJMBHR.2022.3.1.73-82

Ogbuagu, Oluchukwu Obinna, et al. "Enhancing biopharmaceutical supply chains: Strategies for efficient drug formulary development in emerging markets." International Journal of Medical and All Body Health Research, vol. 3, no. 1, 2022, pp. 73-82. https://doi.org/10.54660/IJMBHR.2022.3.1.73-82.

Ogbuagu, O. O., Mbata, A. O., Balogun, O. D., Oladapo, O., Ojo, O. O. and Muonde, M. (2022) 'Enhancing biopharmaceutical supply chains: Strategies for efficient drug formulary development in emerging markets', International Journal of Medical and All Body Health Research, 3(1), pp. 73-82. doi: 10.54660/IJMBHR.2022.3.1.73-82.

Ogbuagu OO, Mbata AO, Balogun OD, Oladapo O, Ojo OO, Muonde M. Enhancing biopharmaceutical supply chains: Strategies for efficient drug formulary development in emerging markets. International Journal of Medical and All Body Health Research. 2022;3(1):73-82. doi:10.54660/IJMBHR.2022.3.1.73-82

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.